AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Biohit Oyj

Board/Management Information Jun 28, 2021

3304_rns_2021-06-28_6e712105-b7bf-48d9-9995-8a2abaa652ca.html

Board/Management Information

Open in Viewer

Opens in native device viewer

Changes in Management Team

Changes in Management Team

Biohit Oyj stock exchange release 28[th] of June 2021 at 02.00 pm local time
(EET)

Changes in management team

Biotechnology and food engineer, Production Manager Suvi Elomaa starts on 1[st]
of July as Biohit's Production Director and part of the Management Team. Suvi
Elomaa has worked at Biohit since 2013.

Microbiologist and computer science engineer (p.hD.) Minna Mäki continues as
company’s R&D Director and part of the Management Team. The change is part of
Biohit's operational development program.

Additional information:
Deputy CEO Osmo Suovaniemi, Biohit Oyj
tel. +358 9 773 861

[email protected]
www.biohithealthcare.com

Biohit in brief

Biohit Oyj is a globally operating Finnish biotechnology company. Biohit mission
is “Innovating for Health” – we produce innovative products and services to
promote research and early diagnosis. Biohit is headquartered in Helsinki,
Finland, and has subsidiaries in Italy and the UK. Biohit Series B share (BIOBV)
is quoted on Nasdaq Helsinki in the Small cap/Healthcare group.
www.biohithealthcare.com (https://www.globenewswire.com/Tracker?data=ciyb_iZ945H2
z3sK3a9i7Zs03Nkj9jr5Brw7kC1tsoUye5PVgko06PC57Z9BVVT2pXUgp6sn
-tswLd2MUgQOQc8UNXD2BkNm3L02XzRJ7XfJCPaPUqGS1mpI0NZinK5T)

Talk to a Data Expert

Have a question? We'll get back to you promptly.